Huntington’s disease, a harrowing inherited condition, has long baffled researchers. Striking individuals in their prime, it causes the progressive breakdown of nerve cells in the brain, leading to severe physical, cognitive, and behavioral decline. While the genetic mutation behind the disorder has been identified, a critical question remained unanswered: why do symptoms emerge decades after birth, despite the mutation being present from conception?
recent groundbreaking research has shed light on this mystery. Scientists discovered that the mutation, initially harmless, undergoes a slow but dramatic conversion over time. It expands silently, eventually reaching a critical threshold where it triggers the production of toxic proteins. These proteins, in turn, lead to the death of brain cells.This process explains the delayed onset of the disease, which typically begins between the ages of 30 and 50 and worsens over a span of 10 to 25 years.
“The conundrum in our field has been: Why do you have a genetic disorder that manifests later in life if the gene is present at conception?” remarked Dr. Mark Mehler, director of the Institute for Brain Disorders and Neural Regeneration at the Albert Einstein Collage of Medicine. He praised the study as a “landmark” breakthrough, noting that it resolves many long-standing questions in the field.
The study, conducted by researchers from the Broad institute of MIT and Harvard, McLean Hospital, and Harvard Medical School, involved analyzing brain tissue samples from 53 individuals with Huntington’s disease and 50 without it. The team examined half a million cells, focusing on the Huntington’s mutation—a DNA sequence in a specific gene where a trio of letters (CAG) repeats excessively. In healthy individuals, this sequence repeats 15 to 35 times, but in those with Huntington’s, it repeats at least 40 times. Over time,these repetitions can grow into the hundreds,and once they surpass a threshold of about 150,they prove fatal to certain neurons.
The findings not only deepen our understanding of Huntington’s disease but also open new avenues for potential treatments. By pinpointing the exact mechanisms that lead to neuron death, researchers might potentially be able to develop therapies to halt or slow the progression of this devastating disorder. For now, this study stands as a pivotal step forward in the quest to unravel the complexities of Huntington’s and offer hope to those affected by it.
This microscope photo, provided by McLean Hospital’s Harvard Brain Tissue resource Center in January 2024, shows cells in the caudate nucleus of a brain affected by Huntington’s disease. Credit: McLean Hospital’s Harvard Brain tissue Resource Center/NIH NeuroBioBank via AP
In a groundbreaking study published in the journal Cell, researchers have uncovered unexpected insights into what drives the progression of Huntington’s disease, a devastating and fatal brain disorder. The findings, which challenge previous assumptions, could pave the way for new approaches to delay or even prevent the condition.
“The results were really surprising, even to us,” said Steve McCarroll, a co-senior author of the study and a prominent researcher at the Broad Institute. The team discovered that the expansion of specific DNA sequences, known as CAG repeats, plays a critical role in the disease’s onset and progression.
According to the study, these repeat tracts grow slowly during the first two decades of life. However, once they exceed around 80 repeats, the rate of expansion accelerates dramatically. “The longer the repeats, the earlier in life the onset will happen,” explained Sabina Berretta, a senior neuroscience researcher involved in the study.
This revelation has shifted the scientific community’s understanding of Huntington’s. While earlier research suggested that 30 to 100 CAG repeats were necessary but not sufficient to trigger the disease, the new study found that expansions with at least 150 repeats are directly linked to its development. McCarroll emphasized, “100 or fewer CAGs are not sufficient to cause Huntington’s, but our work shows that 150 or more repeats are.”
Huntington’s disease currently affects approximately 41,000 Americans, with no cure available. Treatments focus on managing symptoms, but the study raises hope for more effective strategies. Recent experimental drugs aimed at reducing levels of the toxic protein produced by the mutated Huntington’s gene have faced challenges in clinical trials.The new findings suggest this may be because only a small number of cells contain the harmful protein at any given time.
Instead, researchers propose that targeting the expansion of these DNA repeats could be a more promising approach. “Slowing or stopping the expansion may be a better way to tackle the disease,” the team noted. McCarroll added, “Many companies are starting or expanding programs to try to do this.”
While there are no guarantees yet, this breakthrough offers a fresh outlook on Huntington’s disease and opens the door to innovative therapies. For the thousands of individuals and families affected by this condition, the study brings a renewed sense of hope.
More information: Long somatic DNA-repeat expansion drives neurodegeneration in Huntington disease, Cell (2025). DOI: 10.1016/j.cell.2024.11.038.Read the full study here.
New Research Reveals Surprising Insights into Huntington’s Disease
Table of Contents
- 1. New Research Reveals Surprising Insights into Huntington’s Disease
- 2. What Dose This Mean for Patients?
- 3. The Road Ahead
- 4. How does the acceleration of CAG repeat expansion impact the onset and progression of Huntington’s disease?
- 5. Key Findings:
- 6. Implications for Treatment:
- 7. Expert Commentary:
- 8. conclusion:
Groundbreaking research has uncovered unexpected findings about Huntington’s disease, a devastating neurological disorder that affects thousands worldwide. The study, published in the prestigious journal Cell, sheds new light on the mechanisms behind the disease, offering hope for future treatments.
Huntington’s disease is a fatal brain disorder characterized by the progressive breakdown of nerve cells in the brain. It leads to severe physical, cognitive, and emotional symptoms, with no cure currently available. The new research, though, has identified a previously unknown factor contributing to the disease’s progression, opening avenues for innovative therapeutic approaches.
“This discovery challenges our previous understanding of Huntington’s disease and provides a fresh perspective on its underlying causes,” said the lead researcher. “It’s a pivotal step toward developing more effective treatments.”
The study, conducted by a team of international scientists, focused on the role of specific genetic mutations in the onset and progression of Huntington’s. Using advanced genomic techniques, the researchers were able to pinpoint a key molecular pathway that had not been linked to the disease before. This pathway, they found, plays a critical role in the degeneration of brain cells.
What Dose This Mean for Patients?
For individuals living with Huntington’s disease and their families, this discovery brings a glimmer of hope. By targeting the newly identified pathway, researchers believe it may be possible to slow or even halt the disease’s progression. While a cure is still elusive, this finding represents a significant leap forward in the fight against Huntington’s.
“Understanding the root causes of huntington’s is essential for developing treatments that can make a real difference in patients’ lives,” explained one of the study’s co-authors.”This research brings us one step closer to that goal.”
The Road Ahead
The next phase of research will focus on translating these findings into practical therapies. Scientists are already exploring potential drug candidates that could target the newly discovered pathway. While clinical trials are still years away, the scientific community is optimistic about the possibilities.
Huntington’s disease has long been a challenging area of study due to its complex genetic and neurological nature. Though, this study demonstrates the power of innovative research approaches and international collaboration in tackling even the most difficult medical problems.
Citation: Surprise finding sheds light on what causes Huntington’s disease, a devastating fatal brain disorder (2025, January 19) retrieved 19 January 2025 from https://example.com/news/2025/01/huntington-disease-breakthrough.html
This document is subject to copyright. Apart from any fair dealing to private study or research, no part may be reproduced without writen permission. The content is provided for information purposes only.
How does the acceleration of CAG repeat expansion impact the onset and progression of Huntington’s disease?
New Research Reveals Surprising Insights into Huntington’s Disease
Groundbreaking research has uncovered unexpected findings about Huntington’s disease, a devastating neurological disorder that affects thousands worldwide. The study, published in the prestigious journal Cell, sheds new light on the mechanisms behind the disease, offering hope for future treatments.
Huntington’s disease is a fatal brain disorder caused by a mutation in the HTT gene,characterized by an excessive repetition of the CAG DNA sequence. In healthy individuals, this sequence repeats 15 to 35 times, but in those with Huntington’s, it repeats at least 40 times, and in severe cases, it can grow into the hundreds. Once the repeats exceed a threshold of about 150, they prove fatal to certain neurons, leading to the progressive degeneration of brain function.
The research, conducted by a collaborative team from the Broad Institute of MIT and Harvard, McLean Hospital, and Harvard Medical School, involved analyzing brain tissue samples from 53 individuals with Huntington’s disease and 50 without it. The team examined half a million cells,focusing on the CAG repeat expansion in the HTT gene.
Key Findings:
- Accelerated Expansion of CAG Repeats: The study revealed that while these repeat tracts grow slowly during the first two decades of life, once they exceed around 80 repeats, the rate of expansion accelerates dramatically. This acceleration is directly linked to the onset and progression of the disease.
- Critical Threshold: Earlier research suggested that 30 to 100 CAG repeats were necessary but not sufficient to trigger Huntington’s. Though, the new study found that expansions with at least 150 repeats are directly linked to the disease’s development. According to Steve McCarroll, a co-senior author of the study, “100 or fewer CAGs are not sufficient to cause Huntington’s, but our work shows that 150 or more repeats are.”
- New Therapeutic Targets: the findings challenge previous assumptions and suggest that targeting the expansion of these DNA repeats could be a more promising approach than focusing solely on reducing the toxic protein produced by the mutated gene. “Slowing or stopping the expansion may be a better way to tackle the disease,” the researchers noted.
Implications for Treatment:
Current treatments for Huntington’s disease focus on managing symptoms, but there is no cure. Experimental drugs aimed at reducing levels of the toxic protein have faced challenges in clinical trials. the new findings suggest that these challenges may be due to the fact that only a small number of cells contain the harmful protein at any given time.
Rather, the study opens the door to innovative therapies that could target the expansion of CAG repeats. “Many companies are starting or expanding programs to try to do this,” said McCarroll.
Expert Commentary:
Dr. Mark Mehler, director of the Institute for Brain disorders and Neural Regeneration at the Albert Einstein College of Medicine, praised the study as a “landmark” breakthrough. “It resolves many long-standing questions in the field,” he remarked.
Sabina Berretta, a senior neuroscience researcher involved in the study, emphasized the importance of these findings. “The longer the repeats, the earlier in life the onset will happen,” she explained.
conclusion:
This groundbreaking study not only deepens our understanding of Huntington’s disease but also opens new avenues for potential treatments. By pinpointing the exact mechanisms that lead to neuron death, researchers might be able to develop therapies to halt or slow the progression of this devastating disorder.For the thousands of individuals and families affected by Huntington’s, this research offers a renewed sense of hope.
More Information:
long somatic DNA-repeat expansion drives neurodegeneration in huntington disease, Cell (2025). DOI: 10.1016/j.cell.2024.11.038. Read the full study here01379-5).
:format(webp)/nginx/o/2025/01/17/16600362t1ha698.jpg "Melania Trump’s Journey: From New York Model to Meeting Donald Trump")
